ALGN vs. SNN: Align vs. Smith & Nephew Stock Comparison

Company Profile

Align (ALGN) and Smith & Nephew (SNN) both belong to the Health Care Equipment & Supplies industry, though ALGN is classified under Health Care Supplies while SNN falls under Health Care Equipment.

Align (ALGN) trades as ordinary local shares, while Smith & Nephew (SNN) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Align (ALGN) has an aggressive beta of 1.67, indicating higher sensitivity to broad-market moves, while Smith & Nephew (SNN) is defensive at 0.49 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Align (ALGN) at 11.91% and Smith & Nephew (SNN) at 11.85% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

For every dollar of sales, both Align (ALGN) at 11.83% and Smith & Nephew (SNN) at 10.08% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Align (ALGN) at 20.13% and Smith & Nephew (SNN) at 14.47% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Smith & Nephew (SNN) at 6.09% is around its peer norm for revenue growth, while Align (ALGN) at 0.90% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Smith & Nephew (SNN) at 52.34% sits in the top EPS growth quartile, while Align (ALGN) at 0.53% is closer to the peer norm — faster per-share earnings growth for SNN.

Growth Metrics

Financial Strength

Both Align (ALGN) at 1.43 and Smith & Nephew (SNN) at 2.14 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Align (ALGN) at 0.03 keeps leverage in the lower industry quartile, while Smith & Nephew (SNN) at 0.73 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Align (ALGN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Smith & Nephew (SNN) reports a yield of 1.24%, ranking against industry peers normally.

Align (ALGN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Smith & Nephew (SNN) reports a payout of 53.20%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Align (ALGN) at 24.20 and Smith & Nephew (SNN) at 21.19 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

On P/S ratio, both Align (ALGN) at 2.81 and Smith & Nephew (SNN) at 2.07 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Align (ALGN) at 2.73 sits near its industry’s typical P/B ratio, while Smith & Nephew (SNN) at 12.80 prices above its benchmark range — SNN looks rich relative to book.

Valuation Metrics